Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients

Andrew Y. Sun, Bryan D Hinck, Benjamin R. Cohen, Karen Keslar, Robert L. Fairchild, Manoj Monga

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: Intrarenal inflammation has been implicated in the pathogenesis of nephrolithiasis, with prior work showing increased urine levels of IL-6, IL-8, and CCL-2 in stone patients. However, no studies have assessed for inflammation in the renal papillae. We sought to characterize novel papillary tip and urinary biomarkers in stone patients. Materials and Methods: Ninety-two patients with nephrolithiasis undergoing percutaneous nephrolithotomy were enrolled. Papillary tip biopsies, kidney urine, and bladder urine were collected, as well as voided urine from eight healthy volunteers. Quantitative polymerase chain reaction was performed to measure inflammatory gene expression. Results: Initial 84-gene polymerase chain reaction array revealed significant elevation of several cytokines in stone patients vs controls (fold change 2.3-694). Twenty-four genes were selected for final analysis. In 41 pairs of urine samples, levels of CCL5, CD40, FasL, RIPK2, SELE, TLR3, and IL-15 were significantly elevated in kidney vs bladder urine (p0.0001-0.04). In 23 triplets of samples, expression of these cytokines plus CCL2, CCL7, CCR2, CSF1, CXCL9, and CXCL10, was significantly greater in papillary tips vs urine samples (p0.001-0.05). Cytokine elevation was independent of maximum postoperative heart rate, respiratory rate, temperature, leukocyte count, urinary tract infection in the past year, presence or absence of antibiotics at the time of surgery, and stone composition (all p > 0.05). Conclusion: Expression of CCL-2, CCL-5, CCL-7, CCR-2, CD40, CSF1, CXCL-9, CXCL-10, Fas-L, RIPK2, SELE, and TLR-3 is markedly elevated in the papillary tips, kidney urine, and bladder urine of nephrolithiasis patients. Cytokine elevation was independent of signs of systemic inflammation. These findings further support the role of inflammation in nephrolithiasis and imply that the inflammatory process likely begins at the renal papillae. These may represent novel biomarkers of stone disease, which may be useful in basic nephrolithiasis research, disease diagnosis, and prognosis.

Original languageEnglish (US)
Pages (from-to)236-244
Number of pages9
JournalJournal of Endourology
Volume32
Issue number3
DOIs
StatePublished - Mar 1 2018
Externally publishedYes

Fingerprint

Nephrolithiasis
Urine
Cytokines
Kidney
Inflammation
Urinary Bladder
Biomarkers
Percutaneous Nephrostomy
Interleukin-15
Polymerase Chain Reaction
Respiratory Rate
Interleukin-8
Leukocyte Count
Urinary Tract Infections
Genes
Interleukin-6
Healthy Volunteers
Heart Rate
Anti-Bacterial Agents
Biopsy

Keywords

  • biomarkers
  • gene expression
  • inflammation
  • nephrolithiasis
  • papillary tip

PubMed: MeSH publication types

  • Journal Article

Cite this

Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients. / Sun, Andrew Y.; Hinck, Bryan D; Cohen, Benjamin R.; Keslar, Karen; Fairchild, Robert L.; Monga, Manoj.

In: Journal of Endourology, Vol. 32, No. 3, 01.03.2018, p. 236-244.

Research output: Contribution to journalArticle

Sun, Andrew Y. ; Hinck, Bryan D ; Cohen, Benjamin R. ; Keslar, Karen ; Fairchild, Robert L. ; Monga, Manoj. / Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients. In: Journal of Endourology. 2018 ; Vol. 32, No. 3. pp. 236-244.
@article{14db3d7a554e4804b5e6972339e9813b,
title = "Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients",
abstract = "Introduction: Intrarenal inflammation has been implicated in the pathogenesis of nephrolithiasis, with prior work showing increased urine levels of IL-6, IL-8, and CCL-2 in stone patients. However, no studies have assessed for inflammation in the renal papillae. We sought to characterize novel papillary tip and urinary biomarkers in stone patients. Materials and Methods: Ninety-two patients with nephrolithiasis undergoing percutaneous nephrolithotomy were enrolled. Papillary tip biopsies, kidney urine, and bladder urine were collected, as well as voided urine from eight healthy volunteers. Quantitative polymerase chain reaction was performed to measure inflammatory gene expression. Results: Initial 84-gene polymerase chain reaction array revealed significant elevation of several cytokines in stone patients vs controls (fold change 2.3-694). Twenty-four genes were selected for final analysis. In 41 pairs of urine samples, levels of CCL5, CD40, FasL, RIPK2, SELE, TLR3, and IL-15 were significantly elevated in kidney vs bladder urine (p0.0001-0.04). In 23 triplets of samples, expression of these cytokines plus CCL2, CCL7, CCR2, CSF1, CXCL9, and CXCL10, was significantly greater in papillary tips vs urine samples (p0.001-0.05). Cytokine elevation was independent of maximum postoperative heart rate, respiratory rate, temperature, leukocyte count, urinary tract infection in the past year, presence or absence of antibiotics at the time of surgery, and stone composition (all p > 0.05). Conclusion: Expression of CCL-2, CCL-5, CCL-7, CCR-2, CD40, CSF1, CXCL-9, CXCL-10, Fas-L, RIPK2, SELE, and TLR-3 is markedly elevated in the papillary tips, kidney urine, and bladder urine of nephrolithiasis patients. Cytokine elevation was independent of signs of systemic inflammation. These findings further support the role of inflammation in nephrolithiasis and imply that the inflammatory process likely begins at the renal papillae. These may represent novel biomarkers of stone disease, which may be useful in basic nephrolithiasis research, disease diagnosis, and prognosis.",
keywords = "biomarkers, gene expression, inflammation, nephrolithiasis, papillary tip",
author = "Sun, {Andrew Y.} and Hinck, {Bryan D} and Cohen, {Benjamin R.} and Karen Keslar and Fairchild, {Robert L.} and Manoj Monga",
year = "2018",
month = "3",
day = "1",
doi = "10.1089/end.2017.0699",
language = "English (US)",
volume = "32",
pages = "236--244",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients

AU - Sun, Andrew Y.

AU - Hinck, Bryan D

AU - Cohen, Benjamin R.

AU - Keslar, Karen

AU - Fairchild, Robert L.

AU - Monga, Manoj

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Introduction: Intrarenal inflammation has been implicated in the pathogenesis of nephrolithiasis, with prior work showing increased urine levels of IL-6, IL-8, and CCL-2 in stone patients. However, no studies have assessed for inflammation in the renal papillae. We sought to characterize novel papillary tip and urinary biomarkers in stone patients. Materials and Methods: Ninety-two patients with nephrolithiasis undergoing percutaneous nephrolithotomy were enrolled. Papillary tip biopsies, kidney urine, and bladder urine were collected, as well as voided urine from eight healthy volunteers. Quantitative polymerase chain reaction was performed to measure inflammatory gene expression. Results: Initial 84-gene polymerase chain reaction array revealed significant elevation of several cytokines in stone patients vs controls (fold change 2.3-694). Twenty-four genes were selected for final analysis. In 41 pairs of urine samples, levels of CCL5, CD40, FasL, RIPK2, SELE, TLR3, and IL-15 were significantly elevated in kidney vs bladder urine (p0.0001-0.04). In 23 triplets of samples, expression of these cytokines plus CCL2, CCL7, CCR2, CSF1, CXCL9, and CXCL10, was significantly greater in papillary tips vs urine samples (p0.001-0.05). Cytokine elevation was independent of maximum postoperative heart rate, respiratory rate, temperature, leukocyte count, urinary tract infection in the past year, presence or absence of antibiotics at the time of surgery, and stone composition (all p > 0.05). Conclusion: Expression of CCL-2, CCL-5, CCL-7, CCR-2, CD40, CSF1, CXCL-9, CXCL-10, Fas-L, RIPK2, SELE, and TLR-3 is markedly elevated in the papillary tips, kidney urine, and bladder urine of nephrolithiasis patients. Cytokine elevation was independent of signs of systemic inflammation. These findings further support the role of inflammation in nephrolithiasis and imply that the inflammatory process likely begins at the renal papillae. These may represent novel biomarkers of stone disease, which may be useful in basic nephrolithiasis research, disease diagnosis, and prognosis.

AB - Introduction: Intrarenal inflammation has been implicated in the pathogenesis of nephrolithiasis, with prior work showing increased urine levels of IL-6, IL-8, and CCL-2 in stone patients. However, no studies have assessed for inflammation in the renal papillae. We sought to characterize novel papillary tip and urinary biomarkers in stone patients. Materials and Methods: Ninety-two patients with nephrolithiasis undergoing percutaneous nephrolithotomy were enrolled. Papillary tip biopsies, kidney urine, and bladder urine were collected, as well as voided urine from eight healthy volunteers. Quantitative polymerase chain reaction was performed to measure inflammatory gene expression. Results: Initial 84-gene polymerase chain reaction array revealed significant elevation of several cytokines in stone patients vs controls (fold change 2.3-694). Twenty-four genes were selected for final analysis. In 41 pairs of urine samples, levels of CCL5, CD40, FasL, RIPK2, SELE, TLR3, and IL-15 were significantly elevated in kidney vs bladder urine (p0.0001-0.04). In 23 triplets of samples, expression of these cytokines plus CCL2, CCL7, CCR2, CSF1, CXCL9, and CXCL10, was significantly greater in papillary tips vs urine samples (p0.001-0.05). Cytokine elevation was independent of maximum postoperative heart rate, respiratory rate, temperature, leukocyte count, urinary tract infection in the past year, presence or absence of antibiotics at the time of surgery, and stone composition (all p > 0.05). Conclusion: Expression of CCL-2, CCL-5, CCL-7, CCR-2, CD40, CSF1, CXCL-9, CXCL-10, Fas-L, RIPK2, SELE, and TLR-3 is markedly elevated in the papillary tips, kidney urine, and bladder urine of nephrolithiasis patients. Cytokine elevation was independent of signs of systemic inflammation. These findings further support the role of inflammation in nephrolithiasis and imply that the inflammatory process likely begins at the renal papillae. These may represent novel biomarkers of stone disease, which may be useful in basic nephrolithiasis research, disease diagnosis, and prognosis.

KW - biomarkers

KW - gene expression

KW - inflammation

KW - nephrolithiasis

KW - papillary tip

UR - http://www.scopus.com/inward/record.url?scp=85044746131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044746131&partnerID=8YFLogxK

U2 - 10.1089/end.2017.0699

DO - 10.1089/end.2017.0699

M3 - Article

VL - 32

SP - 236

EP - 244

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 3

ER -